ZH
RU
ES

Domestic marketed drugs

Domestic marketed drugs, Total:64 items.

In the international standard classification, Domestic marketed drugs involves: HEALTH CARE TECHNOLOGY, Medical sciences and health care facilities in general, Pharmaceutics, Test conditions and procedures in general, Products of non-ferrous metals, Construction industry, Buildings, Products of the chemical industry, Freight distribution of goods, General methods of tests and analysis for food products.


IX-EU/EC, Domestic marketed drugs

  • 93/41/EEC-1993 Council Directive Repealing Directive 87/22/EEC on the Approximation of National Measures Relating to the Placing on the Market of High- Technology Medicinal Products, Particularly Those Derived from Biotechnology
  • 87/22/EEC-1986 Council Directive on the Approximation of National Measures Relating to the Placing on the Market of High- Technology Medicinal Products, Particularly Those Derived from Biotechnology
  • 2009/C 185/07-2009 NOTICES FROM MEMBER STATES List of Product Contact Points nominated by the Member States to deal with procedures relating to the application of certain national technical rules to products lawfully marketed in another Member State
  • 2007/C 203/04-2007 Summary of Community decisions on marketing authorizations in respect of medicinal products - Issuing, maintenance or modification of a national marketing authorisation
  • 2008/31/EC-2008 DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 98/8/EC concerning the placing of biocidal products on the market, as regards the implementing powers conferred on the Commission
  • 2016/C 014/02-2016 Commission communication in the framework of the implementation of Directive 2014/31/EU of the European Parliament and of the Council of 26 February 2014 on the harmonisation of the laws of the Member States relating to the making available on the market
  • 2007/C 266/06-2007 Medicinal products - List of marketing authorisations granted by the EEA EFTA States for the second half of 2006 Subcommittee I - On the free movement of goods
  • 2014/28/EU-2014 DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the harmonisation of the laws of the Member States relating to the making available on the market and supervision of explosives for civil uses (recast) (Text with EEA relevance)
  • NO 1451/2007-2007 COMMISSION REGULATION on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
  • 2001/36/EC-2001 Commission Directive Amending Council Directive 91/414/EEC Concerning the Placing of Plant Protection Products on the Market
  • 2002/76/EC-2002 Commission Directive Amending the Annexes to Council Directives 86/362/EEC and 90/642/EEC as Regards the Fixing of Maximum Levels for Pesticide Residues (Metsulfuron Methyl) in and on Cereals and Certain Products of Plant Origin, Including Fruit and Veget
  • NO 2032/2003-2003 COMMISSION REGULATION on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/ 8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC

United States Navy, Domestic marketed drugs

US-CFR-file, Domestic marketed drugs

  • CFR 21-822.9-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.9:What must I include in my submission?
  • CFR 21-822.7-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.7:What should I do if I do not agree that postmarket surveillance is appropriate?
  • CFR 21-814.3-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.3:Definitions.
  • CFR 21-814.84-2013 Food and Drugs. Part814:Premarket approval of medical devices. Section814.84:Reports.
  • CFR 21-814.20-2013 Food and Drugs. Part814:Premarket approval of medical devices. Section814.20:Application.
  • CFR 21-814.39-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.39:PMA supplements.
  • CFR 21-814.100-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.100:Purpose and scope.
  • CFR 21-814.116-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.116:Procedures for review of an HDE.
  • CFR 21-814.44-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.44:Procedures for review of a PMA.
  • CFR 21-814.104-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.104:Original applications.
  • CFR 21-822.3-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.3:How do you define the terms used in this part?
  • CFR 21-814.37-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.37:PMA amendments and resubmitted PMAs.
  • CFR 21-73.3100-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.3100:1,4-Bis[(2-hydroxyethyl)amino]-9,10-anthracenedione bis(2-methyl-2-propenoic)ester co-polymers.

US-FCR, Domestic marketed drugs

  • FCR 21 CFR PART 99-2015 DISSEMINATION OF INFORMATION ON UNAPPROVED/ NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
  • FCR 21 CFR PART 99-2013 DISSEMINATION OF INFORMATION ON UNAPPROVED/ NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES

RU-GOST R, Domestic marketed drugs

  • GOST R 56701-2015 Medicines for medical applications. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals

EU/EC - European Union/Commission Legislative Documents, Domestic marketed drugs

  • 2009/C 146/04-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 May 2009 to 31 May 2009 — Issuing@ maintenance or modification of a national marketing authorisation (Decisions taken pursuant to Article 34 of Directive 20
  • 2016/C 332/03-2016 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2016/C 460/03-2016 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2017/C 076/04-2017 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2016/C 416/03-2016 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2016/C 138/02-2016 Commission communication in the framework of the implementation of Directive 2014/29/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of simple pressure v
  • 2017/C 044/02-2017 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2017/C 118/05-2017 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2016/C 293/02-2016 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2017/C 149/02-2017 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2016/C 249/02-2016 Commission communication in the framework of the implementation of Directive 2014/53/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market of radio equipment a
  • 2017/C 118/02-2017 Commission communication in the framework of the implementation of Directive 2014/28/EU of the European Parliament and of the Council on the harmonisation of the laws of the Member States relating to the making available on the market and supervision of e

German Institute for Standardization, Domestic marketed drugs

  • DIN EN 1991-4/NA:2010 National Annex - Nationally determined parameters - Eurocode 1: Actions on structures - Part 4: Silos and tanks

Professional Standard - Agriculture, Domestic marketed drugs

  • 药典53-2013 Letter on Corrigendum to the Second Supplement of the 2010 Edition of the Chinese Pharmacopoeia
  • 药典55-2014 Announcement on the addition and revision of the appendix Microbiology and Biological Testing of the Third Supplement to the 2010 Edition of the Chinese Pharmacopoeia

Agricultural Standard of the People's Republic of China, Domestic marketed drugs

  • GB 31660.1-2019 National food safety standardDetermination of macrolides residues in fishery products by liquid chromatography-tandem mass spectrometric method

VE-FONDONORMA, Domestic marketed drugs

  Approved Drugs, Domestic listed peptide drugs, Deuterated drugs already on the market, Domestic marketed drugs.

 



Copyright ©2007-2023 ANTPEDIA, All Rights Reserved